BioMérieux’s commitment in the fight against HIV Michel Bonnier VP Public Health.

Slides:

Advertisements

Similar presentations

Stop TB Strategy Planning Frameworks Mukund Uplekar TB Strategy, Operations and Health Systems, Stop TB Department, WHO.

Advertisements

February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.

Nick Curry, MD, MPH Infectious Diseases Prevention Section

Dr. Thaweesak Tirawatnapong Chula Medical Research Center (Chula MRC)

Saving lives, changing minds. Collaborative TB/HIV services for people who use drugs The experience of Red Cross / Red Crescent Lasha Goguadze.

New Directions in the SightFirst Program, Lions Clubs International Foundation Linda Romano-Derr Regional Program Specialist, South Asia New Directions.

Overview of the Global Fund: Guiding Principles Grant Cycle / Processes & Role of Public Private Partnerships Johannesburg, South Africa Tatjana Peterson,

Pediatric Diagnosis of HIV-1 Infection Using Dried Blood Spots Chin-Yih Ou, PhD NCHSTP/DHAP Centers for Disease Control and Prevention.

Missouri Department of Health and Senior Services Center for Local Public Health Services Missouri’s Public Health System.

Christine Lubinski Vice President for Global Health Infectious Diseases Society of America April 17, 2009 Germs Go Global Tuberculosis and HIV/TB Co-Infection.

Technical and Operational Considerations for Scaling Up

Use of Dried Blood Spots (DBS) Specimens for Measuring HIV-1 Viral Load in Argentina M. Lorena Vázquez Inés Zapiola Ana Gun Silvia Gómez Alejandro Krolewiecki.

Working Together to Improve Global Health

Simplification, cost-reduction strategies and examples from the field Teri Roberts Diagnostics Advisor Médecins Sans Frontières, Access Campaign 7th.

Stepping up the Pace Together Dynamic Partnerships Across Community, Academic and Policy Sectors Kevin Miles - Manager of Health Programmes.

Scaling up Prevention of Mother to Child Transmission of HIV (PMTCT): What Will it Take to Eliminate MTCT? Jessica Rodrigues Presentation for UNICEF Written.

Slide 2 Key Points Although HIV/AIDS is found throughout the world, most people living with HIV/AIDS reside in low- and middle-income countries More people.

Technical Advisory Group meeting, WHO/WPRO

Kevin Fenton, MD, PhD, FFPH Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention.

Global Strategy, Policy and Normative Guidance for POC Diagnostics Gottfried Hirnschall MD, MPH Department of HIV/AIDS, World Health Organization July.

Departmental Perspectives on Viral Hepatitis

1 CHILDREN AFFECTED BY HIV/AIDS : Botswana Experience BY MINISTER OF HEALTH BOTSWANA HON. PROF. SHEILA DINOTSHE TLOU DATE 29 NOVEMBER 2007 IRELAND.

The Hong Kong Declaration of The World Association of Chinese Public Health Professionals (WACPHP), 6 March 2004 The World Association of Chinese Public.

DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.

Global Response to HIV/AIDS Nigerian Nurses Association of USA June 30, 2006 Carolyn M Hall, MSN/MPH, ACRN Global HIV/AIDS Program U.S. Department of Health.

Prevention and improved treatment of communicable diseases (HIV/AIDS and TB), including increasing preparedness for bioterrorism and epidemics Anneli Taal,

CDC as a Career Path for Social Workers National Association of Deans and Directors Atlanta, GA October 26, Bryce D. Smith, PhD, MSSW.

Group Discussion Guyana, The Bahamas T & T, Jamaica Barbados, Haiti Suriname, Curacao.

Joan Holloway Vice President, Global Health Initiatives Multidisciplinary Care Team Delivery of Integrated HIV Services.

Global Corporate Citizenship Outcomes of WEC Sessions with the Financial and NGO Communities Jack S. Kace 

Botswana Experience on Public- Private Partnerships Joconiah Chirenda, MD, MPH, MBA Global Business Coalition on.

Ecdc.europa.eu Tommi Asikainen, Tubingen, 22 October 2008 European Centre for Disease Prevention and Control FUTURE DISEASE CHALLENGES IN EUROPE – where.

STD Surveillance Network (SSuN) Cycle 2 Objectives Lori Newman & Kristen Mahle SSuN Principal Collaborators Meeting Atlanta, GA December 2, 2008.

African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.

EPIDEMIOLOGY DENGUE, MALARIA Priority Areas for Planning Dengue Emergency Response 1. Establish a multisectoral dengue action committee.

Result of gap analysis and framework of action required in coming five months August rd Meeting of National Influenza Centres in the Western.

Clinical trials in Framework programme 7 (FP7) EU Judita Kinkorová 2. Národní konference o doporučených postupech, Olomouc 13. listopadu 2010.

End TB Strategy HCW with cough since January. Seen at government clinic thrice with no sputum/CXR. Diagnosed TB in May only.

Corporate Social Responsibility

Storyboard Presentation – Unique Customization February 20-21, 2007 / St. Pete’s Beach, FL Rémi PAULE Deputy Director, Methods & Indicators, Global Manufacturing.

Epilepsy and WHO | 17 Oct |1 | WHO's six-point agenda The overarching health needs 1.Promoting development 2.Fostering health security The strategic.

Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.

2004: 39.4 (35.9 – 44.3) million Western & Central Europe [ – ] North Africa & Middle East [ – 1.5 million] Sub-Saharan.

PUTTING THE PATIENT AT THE CENTER OF HEALTHCARE RESEARCH Towards a more inclusive model.

Cancer Mortality Target Measuring and Monitoring at a National Level Jennifer Benjamin, Department of Health Kathy Elliott, National Cancer Action Team.

Fabio Mesquita, MD, PhD Director of the Brazilian Ministry of Health’s HIV/AIDS and Viral Hepatitis Department July 23th, 2014 TasP – Leadership.

Prevention and Health Promotion Administration - 1 Increasing Engagement in HIV Care through Health Department and Community Health Center Collaboration.

Global Tuberculosis Control 2007 Did we reach the 2005 targets? Will we achieve the Millennium Development Goals?

A Private-Public Partnership Presented at the XVII International AIDS Conference 3rd to 8th August 2008, Mexico City, MEXICO Rene Kiamba.

2007 Pan American Health Organization 2004 Pan American Health Organization Malaria in the Americas: Progress, Challenges, Strategies and Main Activities.

Provider Initiated HIV Counseling and Testing Unit 2: Introduction and Rational for PIHCT.

Global HIV Diagnostics Market share forecast to grow at 9.5% CAGR up to 2023

Implementation of routine HIV viral load monitoring A multisite cascade analysis Munyaradzi Dhodho1, Marthe Frieden1, Amir Shroufi2, Esther Wanjiru3, Sarah.

3rd International HIV/Viral Hepatitis Co-Infection Meeting HIV/Viral Hepatitis: Improving Diagnosis, Antiviral Therapy and Access Sunday, 17 July.

The LAASER program Raphael Hamers, MD

Implementation of routine HIV viral load monitoring A multisite cascade analysis Munyaradzi Dhodho1, Marthe Frieden1, Amir Shroufi2, Esther Wanjiru3, Sarah.

XVII International AIDS Conference

RTA in Brief 1996 – Founded, started distribution of Merial poultry vaccines – Made investments in R&D activities for human health – Moved.

Work Programme The social challenge “Health, Demographic Change and Wellbeing” Maia Okujava NCP for Health, Demographic Change and weii-being,

Lecture 9: PHC As a Strategy For HP Dr J. Sitali

08 Uniting the World against AIDS Introduction

جامعة الملك عبد العزيز كلية الاعمال رابغ

Sarah E. Rutstein, MD, PhD University of North Carolina at Chapel Hill

Pandemics MINI-LESSON

Pandemics MINI-LESSON

Medical Devices : Challenges for Non-Communicable Diseases

Utilization of Audio visual medium for conveying sputum collection instructions for tuberculosis diagnosis Presenter: Fred ORINA.

Performing Sedia Asante: Testing algorithm

Molecular Diagnostics - Europe Market to Hit $3.3 Bn by 2024 : Graphical Research According to the Graphical Research new growth forecast report titled.

Performing Maxim Swift RIA: Testing algorithm

Presentation transcript:

bioMérieux’s commitment in the fight against HIV Michel Bonnier VP Public Health

2 bioMérieux and Public Health  bioMérieux: Serving the Global Community with Diagnostic Solutions

3 Who is bioMérieux?  A century-long commitment to the fight against infectious diseases

4 bioMérieux at a glance  Pure Player in the In Vitro diagnostics field  Focused on infectious diseases  Over 5,800 employees  Present in over 150 countries 38 subsidiaries and more than 100 distributors 15 production sites & 11 R&D sites Particular emphasis in Africa, and a strengthened presence in Asia Complete coverage of Latin America and a historic base in Europe

5 A Public Health Department to serve the Global Community  Facilitate access to diagnostics for limited resource countries by guiding the company to respond to public health programs  Committed to making innovation in diagnostics accessible to all healthcare settings  Committed to building partnerships with international organizations and foundations  Focusing its efforts on HIV / AIDS & Tuberculosis

6 bioMérieux’s commitment to HIV  bioMérieux’s commitment to HIV testing started 25 years ago  A wide range of products for screening, preventing mother-to- child transmission and improving patient care  Development of specific applications to address Public Health challenges: Protocol for viral load testing using the Dry Blood Spot

7 bioMérieux HIV Product portfolio  Prevention & Diagnosis: Multiple solutions for HIV Testing - VIKIA HIV rapid test: for use by healthcare professionals - VIDAS / mini VIDAS “Load and Go” immunoanalyser for HIV routine and emergency testing - VIDIA: Primary tube immunoanalyser for HIV routine testing - Vironostika: Microtiter plate immunoanalyser for high-volume HIV screening

8 bioMérieux HIV Product portfolio  Monitoring: Real Time HIV Viral Load Assay - Nucleic Acid extraction systems: NucliSENS miniMAG or NucliSENS easyMAG - and Molecular Analyser for real-time NASBA amplification and detection: NucliSENS EasyQ

 bioMérieux: Serving the Global Community with Diagnostic Solutions